28/11/2017
Auris Medical Reports Third Quarter 2017 Financial Results and Provides Business Update
Auris Medical Holding AG(NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced financial results for the third quarter ended September [...]
